—DHI
— • —
$142.64
P/E
12.95
PEG
—
FCF Yield
—
Rev Growth YoY
-862.0% YoY
Gross Margin
2361.0%
Health Score
4/10
D/E Ratio
0.25
Confidence
LOW
Business Snapshot
The exchange, sector, and industry data for this ticker are not populated in the payload, making it impossible to precisely characterise the company's business model or competitive market. The current share price of $142.64 and the available valuation ratios (P/E of 12.95x, Price/Sales of 1.23x) suggest a going concern, but the absence of market capitalisation data prevents a definitive size classification. Without these foundational identifiers, this brief must be treated as a highly partial and preliminary assessment.
Financial Health
Score: 4/10
The balance sheet shows a conservative debt profile with a Debt/Equity ratio of just 0.25x, and the current ratio of 4.66x indicates strong short-term liquidity — the company holds roughly $4.66 in current assets for every $1 of near-term obligations. However, free cash flow is unavailable, preventing any assessment of whether earnings are translating into real cash generation...
Risk Assessment
- DATA INTEGRITY: Revenue growth of -862% YoY and gross margin of 2,361% are statistically implausible for normal operations, signalling potential accounting distortions, restatements, or extreme one-time items that make financial analysis unreliable.
- CASH FLOW: Free cash flow is entirely unavailable; without FCF data, it is impossible to confirm whether reported earnings correspond to actual cash generation.
- GROWTH DETERIORATION: Earnings growth of -2,216% YoY represents one of the most severe year-over-year declines observable in standard financial reporting, regardless of cause.
- ANALYST CONSENSUS: Only 37% of covering analysts rate the stock a Buy, with 52% at Hold and the consensus formally at Sell — reflecting a broad lack of institutional conviction.
- TECHNICALS: A confirmed death cross (50-day MA crossing below 200-day MA) with a bearish MACD signal indicates negative price momentum on both medium and longer-term horizons.
---...
**Score: 4/10** The balance sheet shows a conservative debt profile with a Debt/Equity ratio of just 0.25x, and the current ratio of 4.66x indicates strong short-term liquidity — the company holds roughly $4.66 in current assets for every $1 of near-term obligations. However, free cash flow is unavailable, preventing any assessment of whether earnings are translating into real cash generation. The reported gross margin of 2,361% and net margin of 995% are statistical anomalies that almost certainly reflect extreme one-time accounting items or base-period distortions rather than genuine profitability, and should not be interpreted at face value. ---
- **DATA INTEGRITY:** Revenue growth of -862% YoY and gross margin of 2,361% are statistically implausible for normal operations, signalling potential accounting distortions, restatements, or extreme one-time items that make financial analysis unreliable. - **CASH FLOW:** Free cash flow is entirely unavailable; without FCF data, it is impossible to confirm whether reported earnings correspond to actual cash generation. - **GROWTH DETERIORATION:** Earnings growth of -2,216% YoY represents one of the most severe year-over-year declines observable in standard financial reporting, regardless of cause. - **ANALYST CONSENSUS:** Only 37% of covering analysts rate the stock a Buy, with 52% at Hold and the consensus formally at Sell — reflecting a broad lack of institutional conviction. - **TECHNICALS:** A confirmed death cross (50-day MA crossing below 200-day MA) with a bearish MACD signal indicates negative price momentum on both medium and longer-term horizons. ---
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives